Results 91 to 100 of about 121,678 (291)

How do red and infrared low-level lasers affect folliculogenesis cycle in rat’s ovary tissue in comparison with clomiphene under in vivo condition [PDF]

, 2017
Tabriz University of Medical Sciences, 5/89/137Peer reviewedPublisher ...
Alihemmati, Alireza, Hossien Rasta, Seyed, Naseri, Paria   +2 more
core   +3 more sources

Plain Language Summary of the ACCEPT Guideline for the Management of Recurrent Pregnancy Loss

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Recurrent pregnancy loss (RPL) is when a woman experiences two or more pregnancy losses. Investigating for causes of RPL can provide an explanation and possible treatment options. This is a summary of Parts 1 and 2 of Australasian Recurrent Pregnancy Loss Clinical Management Guidelines in an easy‐to‐read patient friendly format. These original
Adriana Suker, Ying Li, Anthony Marren, Danielle Robson, the Australasian CREI (Certificate of Reproductive Endocrinology and Infertility) Consensus Expert Panel on Trial evidence (ACCEPT) group   +4 more
wiley   +1 more source

Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder

Drug, Healthcare and Patient Safety, 2009
Christine Brady, Shaymaa S Mousa, Shaker A MousaThe Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, NY, USAAbstract: In the past, polycystic ovary syndrome has been looked at primarily as an endocrine disorder ...
Christine Brady, Shaymaa S Mousa, Shaker A Mousa   +2 more
doaj  

Variations of Steroid Hormone Metabolites in Serum and Urine in Polycystic Ovary Syndrome after Nafarelin Stimulation: Evidence for an Altered Corticoid Excretion. [PDF]

, 1995
To evaluate the clinical relevance of testing pituitary-ovarian responses in patients suffering from polycystic ovary syndrome (PCOS) with the GnRH agonist nafarelin, a 1.2-mg dose of nafarelin was given intranasally to 19 women with PCOS and 15 healthy ...
A. Lob, Burkhardt Moller, Cornelia H, Dieter Engelhardt, Karl Jacob, Michael M. Weber, Peter Luppa, Rainer Kimmig, Roger, Thomas Strowitzki   +9 more
core   +1 more source

ACCEPT Group Condensed Position Paper on the Management of Recurrent Pregnancy Loss

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT The Australasian CREI (Certificate of Reproductive Endocrinology and Infertility) Consensus Expert Panel on Trial Evidence (ACCEPT) group recently published an evidence‐based guideline on the investigation and management of recurrent pregnancy loss (RPL).
Adriana Suker, Ying Li, Anthony Marren, Danielle Robson, the Australasian CREI (Certificate of Reproductive Endocrinology and Infertility) Consensus Expert Panel on Trial evidence (ACCEPT) Group   +4 more
wiley   +1 more source

Health-related Quality of Life in Women with Polycystic Ovary Syndrome

Medisur, 2014
Polycystic ovary syndrome is the most frequent endocrine and metabolic disorder in women of reproductive age. Its characteristic signs and symptoms are menstrual irregularities, amenorrhea, acne, hirsutism, obesity and infertility.
Belén Carazo Hernández, Olivia Lafalla Bernad, Raquel García Simón, Elena Gascón Mas, Esther Moreno Romea, Beatriz Rojas Pérez-Ezquerra   +5 more
doaj   +2 more sources

Maternal polycystic ovary syndrome and Offspring’s Risk of Cardiovascular diseases in Childhood and Young Adulthood

Nature Communications
Children born to mothers with polycystic ovary syndrome have a higher prevalence of cardiovascular risk factors and of subclinical cardiovascular disease, but the association between maternal polycystic ovary syndrome and cardiovascular disease in ...
Fen Yang, Ziliang Wang, Henrik Toft Sørensen, Imre Janszky, Mika Gissler, Wei Yuan, Maohua Miao, Nathalie Roos, Anna-Karin Wikström, Jiong Li, Krisztina D. László   +10 more
doaj   +1 more source

Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance

Бюллетень сибирской медицины, 2018
Aim. Polycystic ovary syndrome is a common cause of infertility. In addition, polycystic ovary syndrome is often associated with metabolic complications. In most women hyperandrogenic manifestations occur during puberty.
E. M. Bogatyreva, G. A. Novik
doaj   +1 more source

Metformin in polycystic ovary syndrome: systematic review and meta-analysis [PDF]

, 2003
The original publication may be found at www.bmj.comObjective To assess the effectiveness of metformin in improving clinical and biochemical features of polycystic ovary syndrome. Design Systematic review and meta-analysis.
Flight, I., Lord, J., Norman, R.
core   +1 more source

Postprandial Hyperglycaemia Screening and Pregnancy Outcomes‐Lessons From COVID ‐19

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background During COVID‐19, the diagnosis and treatment of GDM differed from conventional criteria. In Australia, during the alternative testing period, women with fasting glucose < 4.7 mmol/L were not diagnosed with GDM. Aim To describe the maternal and neonatal outcomes of pregnant women with fasting blood glucose < 4.7 mmol/L for whom the ...
Beenu Bastian, Lisa Gaye Smithers, Ansar Kunjunju, Alexia Pape, Monique Francois   +4 more
wiley   +1 more source